Donald J. Santel - Jul 30, 2021 Form 3 Insider Report for Oyster Point Pharma, Inc. (OYST)

Role: Director
Signature: /s/ Brandon Fenn, Attorney-in-Fact
Stock symbol: OYST
Transactions as of: Jul 30, 2021
Transactions value $: $0
Form type: 3
Date filed: 8/3/2021, 08:14 PM
Next filing: Aug 13, 2021
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney No Table I or Table II securities beneficially owned